Four Sample Of Piecan Pharma Fail In Quality Tests

Jaipur: Four samples of cefixime antibiotics, produced by the same pharma company that was raided by FDCA in Gujarat, have failed the quality test in Rajasthan.

The seized samples of the antibiotic had no cefixime in them. Piecan Pharma, the drug manufacturer, was raided by FDCA in Gujarat during a crackdown on spurious drugs. The same drugs, also being sold in Rajasthan, were seized by FDCA and Rs 6 lakh worth of the spurious antibiotic was recovered. The state team has informed its Gujarat counterparts.

“The cefixime tablets manufactured by Piecan Pharma failed quality test. We found that it did not contain cefixime content in it,” said Ajay Phatak, drug controller (I), health department. Phatak said, “Spurious drugs racket was busted in Gujarat where action against Piecan Pharma was taken.”

The state’s FSDC also conducted searches. “We found these drugs stored at 13 places. We have seized the stock of these drugs which costs around Rs 6-lakh,” said Phatak.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg